Based on 2 reference(s) in Google Scholar 8 10 2

Axon 2749

CAS [1912399-75-7]

MF C30H24N8O2
MW 528.56

  • Purity: 99%
  • Soluble in DMSO



BT-11 is a first-in-class, orally active lanthionine synthetase C-like 2 (LANCL2) binding compound (Kd value of 7.7 µM) for treating inflammatory bowel disease (IBD). Moreover, BT-11 downregulates expression of pro-inflammatory cytokines (e.g., TNF-α or interferon-γ, which are hallmarks of IBD), and promotes IL-10-mediated anti-inflammatory responses in the GI tract.

KEYWORDS: BT-11 | supplier | LANCL2 modulator | BT11 | BT 11 | CAS [1912399-75-7] | Abscisic acid | LANCL | Modulator | Receptors | IBD

Size Unit Price Stock
5 mg €110.00 In Stock
25 mg €330.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €160.00 In Stock
2 x 25 mg €540.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...